Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

QLT Inc. (QLTI - Analyst Report) recently completed the sale of its punctal plug drug delivery system (PPDS) technology to Mati Therapeutics Inc. Mati was founded by Robert Butchofsky, an ex-president and chief executive officer of QLT .

We remind investors that on Dec 24, 2012, QLT inked an exclusive option deal with Mati. As per the terms of the deal, Mati was granted a 90-day option by QLT to buy the assets related to its PPDS technology for $0.5 million.

Mati exercised the option on Apr 3, 2013 and both the companies inked an asset purchase agreement to accomplish the technology sale. Following the closure of the transaction, QLT received a further $0.75 million from Mati. QLT is eligible to receive milestone payments up to $19.5 million under the deal. The amount will be exceeded in the event of more than 2 drugs hitting the market.

Apart from the milestone payments, QLT is eligible to receive royalties (low single digit) on global sales of all the drugs developed with the aid of the PPDS technology. Moreover, Mati will pay a fee to QLT on non sales related payments received by the former pertaining to the technology. Consequently, the deal is expected to boost Canada-based QLT’s balance sheet significantly.

QLT, which focuses on developing and commercializing innovative ocular products for those with high unmet medical needs, carries a Zacks Rank #1 (Strong Buy). Other Zacks #1 Ranked stocks include Cytokinetics, Incorporated (CYTK - Snapshot Report), Biogen Idec Inc. (BIIB - Analyst Report) and Athersys, Inc. (ATHX - Snapshot Report).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GROUP DXYN 15.84 +7.90%
BOFL HOLDING BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%